Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma von van Rhee, Frits, Szmania, Susann M, Dillon, Myles, van Abbema, Anne M, Li, Xin, Stone, Mary K, Garg, Tarun K, Shi, JuMei, Moreno-Bost, Amberly M, Yun, Rui, Balasa, Balaji, Ganguly, Bishwa, Chao, Debra, Rice, Audie G, Zhan, Fenghuang, Shaughnessy, Jr, John D, Barlogie, Bart, Yaccoby, Shmuel, Afar, Daniel E H

Volltext

747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors von Samhouri, Yazan, Beane, Joal D, Weiss, Sarah, Randolph Hecht, J, Hyngstrom, John, Hanks, Brent A, Ganguly, Bishwa J, Gong, Lucy, Hiraragi, Hajime, Kim, Yeonhee, Nikoo, Navid, Gillenwater, Heidi

Volltext

754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small c... von Spigel, David R, Hamilton, Erika, Bashir, Babar, Gergis, Usama, Murthy, Hemant S, Chumsri, Saranya, Migdady, Yazan, Specht, Jennifer, Chaudhary, Lubna N, Garber, Haven, Kim, Chul, Mamdani, Hirva, Fitzsimmons, Sarah, Ganguly, Bishwa J, Hiraragi, Hajime, Jensen, Helle, Kim, Yeonhee, Lessig, Mary C, Gillenwater, Heidi

Volltext

A CARBON DIOXIDE ADDUCT OF PALBOCICLIB von TYAGI, Vipin, GANGULY, Somenath, PANDA, Tapas, MOHAMMAD, Kallimulla, RAI, Bishwa, Prakash

Volltext bestellen